Opens in a new tab

Abbott Diabetes Care v Powell Gilbert LLP (CoA, 9 January 2025)

Date9 January 2025
CourtCoA
DivisionLuxembourg (LU)
Type of actionAppeal RoP220.2
Registry referenceAPL_46747/2024 · ORD_67618/2024
PartiesAbbott Diabetes Care Inc. v. Powell Gilbert LLP

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 9 January 2025 (UPC_CoA_480/2024 and UPC_CoA_481/2024), the Court of Appeal dismissed Abbott Diabetes Care’s appeal against two orders of The Hague Local Division of 29 July 2024 granting Powell Gilbert, acting as a member of the public, access to the pleadings and evidence in two sets of provisional measures proceedings (EP 2 713 879 and EP 3 831 283) between Abbott and Sibionics. The Court holds that once the first-instance decision has been given, a pending appeal no longer justifies refusing access to protect the integrity of proceedings. The order builds on Ocado v Autostore.

Question

May public access to pleadings and evidence under Rule 262.1(b) be refused while an appeal is pending, or where the decision concerns provisional measures and parallel proceedings exist?

Decision

The request must state its purpose and explain why access is necessary, so that the interests under Art. 45 UPCA can be weighed (paragraphs 9 and 10), those interests include the integrity of proceedings and public order (paragraph 11). The public interest generally arises once a decision is given (paragraphs 12 and 13). Once the first instance has decided, withholding access no longer protects the integrity of its proceedings, even if an appeal is or may be lodged (paragraphs 14 and 16 to 18). The CJEU judgment in API v Commission (C-514/07) is distinguished (paragraph 15). The same principles apply to provisional measures, to later merits proceedings and to proceedings on the same patent or family (paragraphs 19 and 20). As Abbott sought no redactions, the balance favoured access (paragraphs 22 and 23).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 45
Rules of Procedure
Rules 262.1 and 262.2
Case law cited
Ocado v Autostore, Court of Appeal, 10 April 2024, NJOY v Juul Labs, Paris Central Division, 24 April 2024 (relied on by Abbott), CJEU, 21 September 2010, API v Commission, C-514/07

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

Contents of the record

Nature of the act
Appeal RoP220.2
Outcome (Dhenne Avocats summary)
La cour d’appel rejette l’appel d’Abbott et confirme l’accès de Powell Gilbert aux écritures et pièces de deux procédures de mesures provisoires, l’appel pendant ne justifiant pas un refus.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 713 879Mentioned in the analysis (role not qualified)
Also mentioned in 4 other decision(s): Sibio v Abbott Diabetes Care (CoA, 19 August 2024) · Abbott Diabetes Care v Sibio Technology (CFI, 29 July 2024) · Abbott Diabetes Care v Sibio Technology (CFI, UPC_CFI_130/2024, 19 Jun · Abbott Diabetes Care v Sibio Technology (CFI, UPC_CFI_131/2024, 19 Jun
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
EP 3 831 283
Analyte sensor devices, connections, and methods
recorded proprietor: Abbott Diabetes Care Inc
Mentioned in the analysis (role not qualified)
Also mentioned in 8 other decision(s): Sibio v Abbott Diabetes Care (CoA, 14 August 2026) · Sibio Technology v Abbott Diabetes Care (CFI, 21 July 2025) · Abbott Diabetes Care v Sibio Technology (CFI, UPC_CFI_131/2024, 19 Jun · Sibio v Abbott Diabetes Care (CoA, 27 February 2026) · Abbott Diabetes Care v Sibio (CoA, 14 February 2025) · Powell Gilbert LLP v Abbott Diabetes Care (CFI, 29 July 2024) · Abbott Diabetes Care v Sibio Technology (CoA, 26 July 2024) · Abbott Diabetes Care v Sibio Technology (CFI, UPC_CFI_130/2024, 19 Jun
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.